Bristol-Myers Squibb Company (BMY)

Cash ratio

Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash and cash equivalents US$ in thousands 10,209,000 10,346,000 11,464,000 9,123,000 13,979,000
Short-term investments US$ in thousands 464,000 513,000 816,000 130,000 3,242,000
Total current liabilities US$ in thousands 23,417,000 23,774,000 22,262,000 21,890,000 21,868,000
Cash ratio 0.46 0.46 0.55 0.42 0.79

December 31, 2025 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($10,209,000K + $464,000K) ÷ $23,417,000K
= 0.46

See also:

Bristol-Myers Squibb Company Cash Ratio